why choose us

First received: February 27, 2026

Clinical Trial: Longitudinal Outcomes of Patients With Group 3 Pulmonary Hypertension Treated With Iloprost

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Pulmonary Hypertension Due to Lung Diseases

Study Type: OBSERVATIONAL


Official Title: AirFly: Longitudinal Outcomes of Patients With Group 3 Pulmonary Hypertension Treated With Iloprost

Brief Summary: This observational real-world study aims to evaluate the longitudinal clinical outcomes of adult patients with Group 3 pulmonary hypertension (PH), associated with chronic lung diseases such as interstitial lung disease, who are treated with inhaled iloprost in routine clinical practice.Treatment options for Group 3 PH remain limited, and the use of pulmonary vasodilators is controversial due to potential worsening of gas exchange. Inhaled iloprost may provide a more selective approach by targeting well-ventilated…

Read more